Healcerion introduces SONON 300L to the US market, giving primary care providers unprecedented affordability, portability and ease-of-use
Healcerion introduces SONON 300L to the US market, giving primary care providers unprecedented affordability, portability and ease-of-use
ROSEVILLE, Calif., July 9, 2018 /PRNewswire/ -- Healcerion launched the SONON 300L handheld ultrasound device to the US market today, following FDA approval of this innovative wireless device for primary care providers. It provides flexible ultrasound technology at less than 1/10 the cost of a traditional ultrasound machine, with a user interface anyone can learn in minutes.
Healcerion Founder and CEO, Dr. Benjamin Jeongwon Ryu, M.D. says, “SONON 300L is smaller and easier to use than any other ultrasound technology in the US market. It allows PCPs to be more efficient and effective with instant insight to diagnose or refer a patient to a specialist.”
SONON 300L is an advanced diagnostic imaging device that can be used anywhere, with an app downloaded from the Google Play or Apple App Store. It uses a paired tablet or smartphone as a display, where images can be analyzed and shared quickly. The entire device weighs only 13 ounces (370 grams) and has a rechargeable lithium-ion battery, Wi-Fi connectivity and 3G/LTE cellular capability.
SONON 300L also supports medical imaging protocols including DICOM (Digital Imaging and Communications in Medicine) and PACS (Picture Archiving and Communication System). Using intuitive finger-touch control to operate, it provides rapid, accurate diagnostics to improve patient care and improve efficiency. SONON300L has a 3-hour continuous scanning battery life, which far exceeds other handheld ultrasound devices.
The SONON 300L advances patient care via the PCP. Currently, according to The Journal of Family Practice, February 2018, less than 10% of PCPs in the US utilize ultrasound technology for diagnostic use - for example to assess thyroid, carotid, breast, lung and vascular conditions. In other countries with world-class healthcare capabilities and outcomes, a larger percentage of physicians utilize diagnostic ultrasound in primary care. “SONON 300L empowers American physicians to advance their practice to align with state-of-the-art practices,” said Dr. Ryu.
It also provides a new diagnostic ultrasound option for retail clinics, urgent care centers, mini-hospitals, home health care providers, and rural and third-world regions where cost, space, mobility requirements had previously put traditional ultrasound out of reach.
About Healcerion
Founded in 2012 and headquartered in South Korea, Healcerion provides healthcare professionals with mobile technology to enhance the quality of medical care available around the world. The company delivers affordable, high-quality, wireless, handheld ultrasound devices to clinical and remote locations worldwide. Through medical and technology innovation Healcerion is committed to giving back to the global community through a strong CSR (Corporate Social Responsibility) program - removing barriers to the life-saving visibility diagnostic ultrasound can provide to those most urgently in-need.
Media Contact:
Jackie Lucas
Tribal Vision, Public Relations
198123@email4pr.com
978-255-1159
View original content with multimedia:http://www.prnewswire.com/news-releases/first-fda-approved-handheld-ultrasound-device-expands-the-use-of-diagnostic-ultrasound-beyond-obstetrics-in-the-us-300677248.html
SOURCE Healcerion
